The National Cancer Institute (NCI) is offering this grant, Toward Translation of Nanotechnology Cancer Interventions (TTNCI), to support advanced pre-clinical research focused on translating nanotechnology-based cancer diagnostics and therapeutics. This grant is for maturing experimental nanomedicines, including nanoparticles and nano-devices, that demonstrate strong potential to enhance cancer treatment effectiveness. Applications are encouraged for interventions where the combination of structural design and therapeutic/diagnostic cargo delivery is key. The TTNCI awards aim to enable further development of proposed nanotechnology-based interventions to a stage suitable for progression into NCI translational programs, such as the NCI Experimental Therapeutics (NExT) program, accelerating innovative cancer treatment strategies.
Opportunity ID: 336703
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-22-071 |
| Funding Opportunity Title: | Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 23, 2021 |
| Last Updated Date: | Nov 23, 2021 |
| Original Closing Date for Applications: | Nov 17, 2024 |
| Current Closing Date for Applications: | Nov 17, 2024 |
| Archive Date: | Dec 23, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $475,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Special district governments County governments City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Small businesses Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA), entitled “Toward Translation of Nanotechnology Cancer Interventions” (TTNCI), encourages applications for advanced pre-clinical research, supporting translation of nanotechnology-based cancer diagnostics and therapeutics. TTNCI awards are designed to mature experimental nanomedicines relying on nanoparticles and nano-devices which demonstrate strong potential to improve cancer treatment effectiveness due to the combination of nanoparticle/nano-device structural design and/or therapeutic/diagnostic cargo which is delivered. TTNCI awards are expected to enable further development of proposed nanotechnology-based interventions to the stage in which they could continue on a developmental path towards the NCI Experimental Therapeutics (NExT) and other NCI translational programs. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-22-071.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 336703 Full Announcement-PAR-22-071 -> PAR-22-071-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270605 | Apr 17, 2022 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277793 | Nov 01, 2022 | Nov 17, 2024 | View |
Package 1
Mandatory forms
336703 RR_SF424_5_0-5.0.pdf
336703 PHS398_CoverPageSupplement_5_0-5.0.pdf
336703 RR_OtherProjectInfo_1_4-1.4.pdf
336703 PerformanceSite_4_0-4.0.pdf
336703 RR_KeyPersonExpanded_4_0-4.0.pdf
336703 PHS398_ResearchPlan_4_0-4.0.pdf
336703 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
336703 RR_Budget_3_0-3.0.pdf
336703 RR_SubawardBudget30_3_0-3.0.pdf
336703 PHS398_ModularBudget_1_2-1.2.pdf
336703 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
336703 RR_SF424_5_0-5.0.pdf
336703 PHS398_CoverPageSupplement_5_0-5.0.pdf
336703 RR_OtherProjectInfo_1_4-1.4.pdf
336703 PerformanceSite_4_0-4.0.pdf
336703 RR_KeyPersonExpanded_4_0-4.0.pdf
336703 PHS398_ResearchPlan_5_0-5.0.pdf
336703 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
336703 RR_Budget_3_0-3.0.pdf
336703 RR_SubawardBudget30_3_0-3.0.pdf
336703 PHS398_ModularBudget_1_2-1.2.pdf
336703 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
